Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Arthritis drug may curb myocardial damage in acute STEMI

    April 13, 2021

    Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.

  • News

    More evidence MIS-C is a delayed response to SARS-CoV-2

    April 13, 2021

    CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”

  • News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.

  • 1
    News

    Longitudinal associations between income changes and incident CVD

    April 2, 2021

    Is there an association between income change and cardiovascular disease (CVD)?

  • News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

  • News

    The role of aspirin in primary prevention of cardiovascular disease

    April 1, 2021

    Does aspirin have a role in primary prevention of cardiovascular disease?

  • 1
    News

    PCI and CABG for left main disease have equal outcomes at 5 years

    March 31, 2021

    In a patient with left main coronary disease, is percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) a better option when considering long-term (5-year) outcomes?

  • 1
    News

    In-hospital mobility impairment in older MI patients predicts postdischarge functional decline

    March 29, 2021

    Does in-hospital mobility of older patients hospitalized for acute myocardial infarction predict overall functional decline after discharge?

  • 1
    News

    Dapagliflozin may cut risk of HF hospitalization in patients with type 2 diabetes

    March 25, 2021

    What is the Food and Drug Administration–approved indication for dapagliflozin (Farxiga)?

  • News

    Low concordance between troponin assays for ACS

    March 25, 2021

    Concordance between high-sensitivity troponin assays was only 37% for a single blood draw, rising to 75% with serial testing, but still changing management decisions in some patients.

Previous1 … 15 16 17 18 19 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences